Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys

References

1. 1.↵
   1. Berkowitz Z,
   2. Li J,
   3. Richards TB,
   4. Marcus PM

   . Patterns of prostate-specific antigen test use for prostate cancer screening in the United States, 2005–2015. Am J Prev Med 2017;53:909–913.

   OpenUrl
2. 2.↵
   1. Purvis Cooper C,
   2. Merritt TL,
   3. Ross LE,
   4. John LV,
   5. Jorgensen CM

   . To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA test. Prev Med 2004;38:182–191.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Bibbins-Domingo K,
   2. Grossman DC,
   3. Curry SJ

   . The US Preventive Services Task Force 2017 draft recommendation statement on screening for prostate cancer: an invitation to review and comment. JAMA 2017;317:1949–1950.

   OpenUrl
4. 4.↵
   1. Han PK,
   2. Kobrin S,
   3. Breen N,
   4. et al

   . National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med 2013;11:306–14.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Li J,
   2. Berkowitz Z,
   3. Richards TB,
   4. Richardson LC

   . Shared decision making in prostate-specific antigen testing with men older than 70 years. J Am Board Fam Med 2013;26:401–8.

   OpenUrlAbstract/FREE Full Text